NO20052396D0 - Fremgangsmate for fremstilling av spirolactonforbindelser - Google Patents

Fremgangsmate for fremstilling av spirolactonforbindelser

Info

Publication number
NO20052396D0
NO20052396D0 NO20052396A NO20052396A NO20052396D0 NO 20052396 D0 NO20052396 D0 NO 20052396D0 NO 20052396 A NO20052396 A NO 20052396A NO 20052396 A NO20052396 A NO 20052396A NO 20052396 D0 NO20052396 D0 NO 20052396D0
Authority
NO
Norway
Prior art keywords
preparation
spirolactone compounds
spirolactone
compounds
Prior art date
Application number
NO20052396A
Other languages
English (en)
Norwegian (no)
Inventor
Ralph P Volante
Steven A Weissman
Takehiko Iida
Kenichi Asakawa
David M Tschaen
Matthew Heileman
Toshiaki Mase
Kenji Maeda
Toshihiro Wada
Hiroki Sato
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20052396D0 publication Critical patent/NO20052396D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20052396A 2002-10-18 2005-05-13 Fremgangsmate for fremstilling av spirolactonforbindelser NO20052396D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41946402P 2002-10-18 2002-10-18
PCT/US2003/032393 WO2004037170A2 (en) 2002-10-18 2003-10-14 Process for making spirolactone compounds

Publications (1)

Publication Number Publication Date
NO20052396D0 true NO20052396D0 (no) 2005-05-13

Family

ID=32176468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052396A NO20052396D0 (no) 2002-10-18 2005-05-13 Fremgangsmate for fremstilling av spirolactonforbindelser

Country Status (14)

Country Link
US (2) US7368569B2 (ja)
EP (1) EP1558605A2 (ja)
JP (1) JP2006503101A (ja)
KR (1) KR20050056252A (ja)
CN (1) CN1705658A (ja)
AU (1) AU2003284116A1 (ja)
BR (1) BR0315348A (ja)
CA (1) CA2502282A1 (ja)
MX (1) MXPA05004062A (ja)
NO (1) NO20052396D0 (ja)
NZ (1) NZ539001A (ja)
PL (1) PL375926A1 (ja)
RU (1) RU2005115087A (ja)
WO (1) WO2004037170A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006503101A (ja) * 2002-10-18 2006-01-26 メルク エンド カムパニー インコーポレーテッド スピロラクトン化合物の製造方法
AR044283A1 (es) * 2003-05-19 2005-09-07 Merck & Co Inc Procedimeinto para preparar compuestos de espirolactona
EP1912642B1 (en) 2005-07-28 2012-10-17 Merck Sharp & Dohme Corp. A crystalline form of a npy5 antagonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI279402B (en) * 1999-08-20 2007-04-21 Banyu Pharma Co Ltd Spiro compounds having NPY antagonistic activities and agents containing the same
US6803372B2 (en) * 1999-08-20 2004-10-12 Banyu Pharmaceutical Co., Ltd. Spiro compounds
US6462053B1 (en) * 1999-08-20 2002-10-08 Banyu Pharmaceutical Co., Ltd. Spiro compounds
US6605720B1 (en) * 2002-01-28 2003-08-12 Merck & Co., Inc. Process for making spirolactone compounds
JP2006503101A (ja) * 2002-10-18 2006-01-26 メルク エンド カムパニー インコーポレーテッド スピロラクトン化合物の製造方法

Also Published As

Publication number Publication date
US7482449B2 (en) 2009-01-27
PL375926A1 (en) 2005-12-12
WO2004037170A3 (en) 2004-07-01
BR0315348A (pt) 2005-08-23
US7368569B2 (en) 2008-05-06
NZ539001A (en) 2006-10-27
JP2006503101A (ja) 2006-01-26
US20060014950A1 (en) 2006-01-19
KR20050056252A (ko) 2005-06-14
EP1558605A2 (en) 2005-08-03
MXPA05004062A (es) 2005-06-08
AU2003284116A1 (en) 2004-05-13
US20080171888A1 (en) 2008-07-17
CN1705658A (zh) 2005-12-07
WO2004037170A2 (en) 2004-05-06
RU2005115087A (ru) 2006-01-20
CA2502282A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20050136D0 (no) Fremgangsmate for fremstilling av mikropartikler
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
TWI370811B (en) Process for the preparation of ring compounds
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
IL172629A0 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20033408D0 (no) Fremgangsmåte for fremstilling av krystallinske nanopartikler
NO20034003L (no) Fremgangsmåte for fremstilling av imidazolforbindelser
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
HK1093725A1 (en) Process for the preparation of substituted thiazoles
NO20035633D0 (no) Teknisk syntesemetode for fremstilling av tropenol
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20034597L (no) Fremgangsmate for fremstilling av cantaxantin
NO20052396D0 (no) Fremgangsmate for fremstilling av spirolactonforbindelser
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20043455L (no) Fremgangsmate for fremstilling av 7alfa-metylsteroider